Repatha 140 MG/ML sureclickml
Ended Awarded
- Contract number
- SPE2DR26F1G88
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $95,530
Award facts
- Contract value 100% obligated
- $95,529.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $95,529.80 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/mL SureClick auto-injectors. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and was issued on November 12, 2025, with an ultimate completion date of November 13, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through its extensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. Repatha, a PCSK9 inhibitor used for cholesterol management, represents one of the specialty pharmaceutical products the company supplies under its DLA prime vendor agreement. The company's demonstrated capability to meet federal procurement requirements through open competition, combined with its role as a primary pharmaceutical vendor to the Defense Health Agency and other government healthcare systems, positions it as a key supplier within the DLA's medical supply chain infrastructure.
Quick answers
Who was awarded contract SPE2DR26F1G88?
SPE2DR26F1G88 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 12, 2025.
How much is contract SPE2DR26F1G88 worth?
The government has obligated $95,530 on SPE2DR26F1G88.
Is contract SPE2DR26F1G88 an order under another contract?
Yes. SPE2DR26F1G88 is a delivery order under SPE2DR25D2205, an indefinite delivery contract.
Was contract SPE2DR26F1G88 competed?
The extent of competition for SPE2DR26F1G88 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award